The company reported robust results, with the top line growing 30% year over year to $726 million and operating margins ...

Park Hotels & Resorts is the second-largest US lodging REIT, focusing on the upper-upscale hotel segment. The company was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017. Since ...

Watch Ask Your Advisor These Questions Before Investing in Model Portfolios for more from Jason Kephart.

James Hardie Industries Up Nearly 9%, on Pace for Largest Percent Increase in Over a Year — Data Talk James Hardie Industries PLC Sponsored ADR (JHX) is currently at $34.62, up $2.83 or 8.89% --Would ...

Spirit Airlines Inc.'s stock cratered 55% Wednesday, on track for its biggest-ever one-day decline, after the company warned that its equity would be wiped out as part of a restructuring deal that ...

--Up 146.42% year-to-date; on pace for best year on record (Based on available data back to April 3, 2018) --Up 166.48% from 52 weeks ago (Nov. 15, 2023), when it closed at $173.76 ...

At the start of 2019, actively managed exchange-traded funds represented just 2% of the US ETF market. Since then, the ...

Zambia Central Bank Raises Key Lending Rate to 14% from 13.5% Zambia's central bank raised its key lending rate by 50 basis points to tame runaway inflation in Africa's second-biggest copper and ...

Oil prices trade at 2-week lows on bets for a demand slowdown, supply surplus Oil futures declined on Wednesday, with U.S. and global benchmark prices touching their lowest levels in about two weeks ...

Telefonica said the World Bank's arbitration arm sided in its favor in a long-running dispute with Colombia, ordering the Latin American country to pay $379.8 million in compensation.

RWE Plans $1.6 Billion Buyback Due to Expected U.S., Europe Project Delays RWE plans a $1.6 billion share buyback, signaling a change in spending priorities in light of expected delays in the U.S.

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...